· Main considerations
· Main recommendations
· CYP2D6
· Opioid analgesics
· Non-opioid analgesics
· Anaesthetics and sedatives
Drug properties |
· Relative infant dose (RID): % of the weight-adjusted maternal dose o Prefer <10% · Oral bioavailability (OBA): % of dose exempt from first pass metabolism |
Administration |
· Dose · Duration |
Child factors |
Pharmacokinetics: · ↓Kidney/liver clearance if young, small, premature · Especially if repeat doses -> accumulation · Especially if exclusive breastfeeding Pharmacodynamics: · ↑Sensitivity to sedation and resp depression if young, small, premature · Especially if big dose Important PMAs: · Term: 46 weeks · Prem: 54-60 weeks (∝ degree of prematurity) |
Maternal factors |
Pharmacokinetics: · CYP450 phenotype Pharmacodynamics: · Opioid tolerance · Additional narcotics |
Anaesthetics |
· Breastfeeding ok as soon as the mother is properly awake o Low RID (relative infant dose) once awake o Low OBA (oral bioavailability) |
Analgesics |
· Breastfeeding safe for some drugs but not others o Variable RID o Variable OBA · Opioids: o Fentanyl good (low RID and low OBA) o Morphine ok (low RID and moderate OBA) o CYP2D6 drugs bad: codeine, oxycodone, tramadol o If oxycodone: <30-40mg/day o Monitor baby for sedation |
Discussion |
Mother: · Benefits of medications · Pain relief is important · Pain relief promotes breast milk production · If not breastfeeding, must pump or else engorgement/mastitis/dry up Baby: · Risk of medications · Signs of toxicity: especially drowsiness |
Logistical support |
· Equipment for pumping · Private space to feed / pump · Place to store breast milk / formula · Room for partner to come and help · Support from lactation consultant in person or telehealth |
Relevance |
· 15% Oxycodone -> oxymorphone (14x analgesic efficacy) · 10% Codeine -> morphine (10x analgesic efficacy) · Tramadol -> M1 (200x MOP affinity, 4x analgesic efficacy) |
Problem |
· Highly variable activity · Non-inducible |
Poor phenotype |
· 30% Hong Kong Chinese · 10% Caucasians ->↓Clearance ->↑Risk of toxicity |
Ultra-rapid phenotype |
· 30% North Africans, Ethiopians, Arabs · 10% Greeks, Portuguese · 1-3% other -> ↑% Contribution of metabolite -> ↑ Risk of toxicity |
Morphine |
· RID 2-3% · Post-partum use not associated with neonatal adverse events · M6G oral bioav 10% in adults, unknown in children · Clearance is reduced in neonates · Limited studies of morphine PCA |
Oxycodone |
· JCP: RID 2.5% (up to 10%) · AAGBI: RID >10% · Case reports of death · Retrospective analysis showed CNS depression in infants · Greater risk than other opioids · Beware >30-40mg/day |
Fentanyl |
· RID 2-3% · OBA low · Short-term use safe. Lack of long-term data. |
Codeine |
· UK MHRA: take in moderation and for a short duration · FDA: not safe · NPS: not safe. If taken, discard breast milk for 15 hours |
Tramadol |
· Case reports of neonatal death · FDA: warns against use · UKDILAS: use with caution |
Paracetamol |
· Safe · Dose that gets to baby is significantly less than therapeutic |
NSAIDs |
· Aspirin: RID 10%. Risks: toxicity (if analgesic dose), Reye’s syndrome · Ibuprofen safe · Diclofenac safe · Naproxen safe · Celecoxib: safe · Parecoxib: safe |
Ketamine |
· No data on transfer into breast milk |
Clonidine |
· May reduce prolactin secretion · Minimally secreted into milk · Safe for the child |
Local anaesthetics |
· Safe |
Tapentadol |
· No data · Less opioid effect cf. oxycodone · No active metabolites cf. tramadol · CYP2D6 is a minor pathway cf. tramadol |
Volatiles |
· Safe |
Propofol |
· Safe |
Ketamine |
· No data |
Midazolam |
· Moderate first pass metabolism |
Diazepam |
· Active metabolite with very long half life · Significant transfer into breast milk |
Dexmedetomidine |
· No data · RID negligible |
Feedback welcome at ketaminenightmares@gmail.com